Popliteal Plexus Block for Total Knee Arthroplasty

NCT03439787 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-04-25

No results posted yet for this study

Summary

This study aims to assess the analgesic effect of the popliteal plexus block as a supplement to a femoral triangle block in patients undergoing total knee arthroplasty

Conditions

  • Pain, Postoperative

Interventions

DRUG

Bupivacaine-EPINEPHrine 0.5%-1:200,000 Injectable Solution

10 ml

OTHER

Sodium Chloride 0.9 %

10 ml

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Charlotte R Sørensen, MD · Silkeborg Regional Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2018-08-23
Completion
2018-08-23

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03439787 on ClinicalTrials.gov